Remove 2030 Remove Assay Development Remove Disease
article thumbnail

Advances in cell line development

Drug Discovery World

According to Grand View Research, the global cell line development market was valued at $4.81 billion in 2022, a figure that is expected to grow at a compound annual growth rate (CAGR) of 9.81% from 2023 to 2030 1. For instance, mammalian cells are better at providing characteristics that are similar to human physiological conditions.

Vaccine 147
article thumbnail

The evolution of assays for immuno-oncology research

Drug Discovery World

Cancer is a complex heterogenous multistep disease characterised by uncontrolled cell proliferation combined with a dysregulated immune response. Half of people diagnosed with cancer in England and Wales survive their disease for 10 years or more (2010-11) 1. In vitro models All the above approaches involve the use of animal models.

Research 130